Case and Research Letters
Metastatic Crohn Disease Treated With Ustekinumab
Enfermedad de Crohn metastásica tratada con ustekinumab
Servicio de Dermatología, Hospital Universitari de La Plana, Villarreal, Castellón, Spain
Read
4629
Timeswas read the article
1675
Total PDF
2954
Total HTML
Share statistics
array:25 [ "pii" => "S1578219020303966" "issn" => "15782190" "doi" => "10.1016/j.adengl.2020.12.020" "estado" => "S300" "fechaPublicacion" => "2021-02-01" "aid" => "2493" "copyright" => "AEDV" "copyrightAnyo" => "2020" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2021;112:182-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0001731020304166" "issn" => "00017310" "doi" => "10.1016/j.ad.2019.05.015" "estado" => "S300" "fechaPublicacion" => "2021-02-01" "aid" => "2493" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2021;112:182-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "Enfermedad de Crohn metastásica tratada con ustekinumab" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "182" "paginaFinal" => "183" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Metastatic Crohn Disease Treated With Ustekinumab" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 585 "Ancho" => 1305 "Tamanyo" => 196355 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Imagen clínica a), e histológica b).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rosa Ballester Sánchez, Celia Sanchís Sánchez, Beatriz Rodrigo Nicolás, Francisca Valcuende Cavero" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Rosa" "apellidos" => "Ballester Sánchez" ] 1 => array:2 [ "nombre" => "Celia" "apellidos" => "Sanchís Sánchez" ] 2 => array:2 [ "nombre" => "Beatriz" "apellidos" => "Rodrigo Nicolás" ] 3 => array:2 [ "nombre" => "Francisca" "apellidos" => "Valcuende Cavero" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219020303966" "doi" => "10.1016/j.adengl.2020.12.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020303966?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020304166?idApp=UINPBA000044" "url" => "/00017310/0000011200000002/v1_202102020721/S0001731020304166/v1_202102020721/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S1578219020303930" "issn" => "15782190" "doi" => "10.1016/j.adengl.2020.12.019" "estado" => "S300" "fechaPublicacion" => "2021-02-01" "aid" => "2464" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2021;112:184-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Hypertrophic Lichen Planus: Importance of Follow-Up and Clinicopathologic Correlation" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "184" "paginaFinal" => "185" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Liquen plano hipertrófico: importancia del seguimiento y de la correlación clinicopatológica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 904 "Ancho" => 1755 "Tamanyo" => 681564 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0025" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A and B, Epidermal hyperplasia with acanthosis, papillomatosis, and hyperkeratosis. B, Focal loss of stratum basale with discrete lymphocytic infiltrate. C, Infiltrating, crateriform squamous cell tumor. D, Dermal masses composed of keratinocytes with abundant cytoplasm and pale eosinophils with slight nuclear atypia (hematoxylin-eosin, ×4 [A]; ×10 [B]; ×4 [C]; ×10 [D]).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S. Guillen-Climent, S. Porcar Saura, C. Monteagudo, M.D. Ramón Quiles" "autores" => array:4 [ 0 => array:2 [ "nombre" => "S." "apellidos" => "Guillen-Climent" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Porcar Saura" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Monteagudo" ] 3 => array:2 [ "nombre" => "M.D." "apellidos" => "Ramón Quiles" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731020303343" "doi" => "10.1016/j.ad.2019.04.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020303343?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020303930?idApp=UINPBA000044" "url" => "/15782190/0000011200000002/v1_202102100758/S1578219020303930/v1_202102100758/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S1578219020303905" "issn" => "15782190" "doi" => "10.1016/j.adengl.2019.02.028" "estado" => "S300" "fechaPublicacion" => "2021-02-01" "aid" => "2378" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2021;112:180-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Images in Dermatology</span>" "titulo" => "Large Carcinoma of the Scalp Invading the Meninges" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "180" "paginaFinal" => "181" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Extenso carcinoma del cuero cabelludo con invasión meníngea" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:6 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 727 "Ancho" => 750 "Tamanyo" => 47908 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Simó Alari, F. Ballescá, I. Gutiérrez" "autores" => array:3 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Simó Alari" ] 1 => array:2 [ "nombre" => "F." "apellidos" => "Ballescá" ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Gutiérrez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731020301757" "doi" => "10.1016/j.ad.2019.02.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020301757?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020303905?idApp=UINPBA000044" "url" => "/15782190/0000011200000002/v1_202102100758/S1578219020303905/v1_202102100758/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Metastatic Crohn Disease Treated With Ustekinumab" "tieneTextoCompleto" => true "saludo" => "To the Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "182" "paginaFinal" => "183" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "R. Ballester Sánchez, C. Sanchís Sánchez, B. Rodrigo Nicolás, F. Valcuende Cavero" "autores" => array:4 [ 0 => array:3 [ "nombre" => "R." "apellidos" => "Ballester Sánchez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Sanchís Sánchez" ] 2 => array:2 [ "nombre" => "B." "apellidos" => "Rodrigo Nicolás" ] 3 => array:2 [ "nombre" => "F." "apellidos" => "Valcuende Cavero" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Universitari de La Plana, Villarreal, Castellón, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad de Crohn metastásica tratada con ustekinumab" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 586 "Ancho" => 1750 "Tamanyo" => 154477 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Clinical course.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">A 41-year-old woman was evaluated in the dermatology clinic for an asymptomatic ulcer that had first appeared on her left leg 3 months earlier. The lesion had violaceous borders and a keratotic center (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A). The patient had fistulizing ileocolonic Crohn disease, for which she had undergone several surgical procedures (total proctocolectomy, resection of the small intestine, and terminal ileostomy). Her disease was well controlled with infliximab at 5<span class="elsevierStyleHsp" style=""></span>mg/kg every 8 weeks, which she had been taking for the last 9 years.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">A sample was taken for microbiological culture and a biopsy for histopathology. The culture result was negative, and the biopsy revealed a bandlike inflammatory infiltrate at both the superficial level and the deep level. This comprised lymphoid cells and occasional nonnecrotizing granulomas with multinucleated giant cells (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B) and was compatible with metastatic Crohn disease.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Daily topical treatment was started with clobetasol ointment, and the infliximab regimen was intensified temporarily to 4 weeks at the same dose. The lesion healed completely within 2 months. However, erosive crusting lesions appeared gradually at the same site. These progressed slowly until they again became ulcerated (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>A). The infliximab regimen was modified to 6 weeks, and additional treatments were prescribed, as follows: azathioprine 100<span class="elsevierStyleHsp" style=""></span>mg every 24<span class="elsevierStyleHsp" style=""></span>hours (dose adjusted according to thiopurine methyltransferase levels), oral prednisone cycles at 0.5-1<span class="elsevierStyleHsp" style=""></span>mg/kg/d, and intralesional triamcinolone infiltrations. This approach was unsuccessful. The infliximab regimen was subsequently intensified to 4 weeks, and metronidazole 500<span class="elsevierStyleHsp" style=""></span>mg every 8<span class="elsevierStyleHsp" style=""></span>hours was added. Wet-wrap dressings (HydroClean Advance) were applied throughout treatment, and the patient was monitored for signs of superinfection. Despite the treatment prescribed, the ulcers worsened quickly and became larger and deeper (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>B). The patient remained free of digestive symptoms at all times.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">Given the failure of therapy and the new indication of ustekinumab for Crohn disease, we agreed with the Gastroenterology Department to change the therapeutic target and start treatment with ustekinumab in monotherapy according to the established regimen for Crohn disease and based on the patient’s weight. The induction dose administered was 390<span class="elsevierStyleHsp" style=""></span>mg followed by 90<span class="elsevierStyleHsp" style=""></span>mg every 8 weeks subcutaneously. Initiation of ustekinumab led to a rapid improvement in the ulcer from the first month and complete cure in 3 months (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>C), with no adverse effects.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Metastatic Crohn disease is a rare extraintestinal manifestation of Crohn disease. While no epidemiological data are available, it is the least common specific cutaneous manifestation. The condition is characterized by the appearance of heterogeneous cutaneous and subcutaneous lesions comprising noncaseating granulomata at anatomic sites not contiguous to the gastrointestinal tract. It may precede, co-occur with, or follow the gastrointestinal disease. The lesions can mimic other more common skin conditions, such as impetigo, erysipelas, erythema nodosum, and pyoderma gangrenosum.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">Clinical suspicion is essential for biopsy and early diagnosis, since the definitive diagnosis is confirmed by histopathology. The presence of persistent skin lesions in patients with Crohn disease should lead us to suspect this possibility, even if the patient is receiving immunosuppressive or biologic therapy and despite the fact that digestive symptoms have remitted.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">If the patient is receiving treatment with an anti–tumor necrosis factor (TNF) α agent, monitoring drug levels and antibody testing would contribute to better management of therapy, since we could determine whether drug levels were insufficient and whether the cause was underdosing or the presence of antibodies.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Unfortunately, and despite the clinical interest of this approach, the required techniques are not available in many centers or for all biologics.</p><p id="par0040" class="elsevierStylePara elsevierViewall">As there is no standard treatment for this condition, management should be tailored. If the lesions are localized, we can consider local treatments, such as topical corticosteroids or tacrolimus, or even intralesional corticosteroids.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> If there is no response, systemic treatment with oral corticosteroids can be considered. If these fail or are insufficient, then conventional immunosuppressants or biologics can be added.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Cases have been treated with metronidazole, mycophenolate mofetil, ciclosporin, adalimumab, infliximab, certolizumab, thalidomide, surgery, and hyperbaric oxygen therapy.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2–5</span></a> All of the biologics used were anti-TNF-α antibody agents. The only case reported of Crohn disease involving the genital region (vulvar and perineal) was successfully treated with ustekinumab.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Ustekinumab is a monoclonal antibody that targets the p40 subunit of the IL-12 and IL-23 receptors. It has been indicated for Crohn disease since 2017. Given that its therapeutic target is not TNF-α, ustekinumab may prove to be a therapeutic option in patients with metastatic Crohn disease whose treatment with corticosteroids, immunosuppressants, or anti-TNF-α agents has failed.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Ballester Sánchez R, Sanchís Sánchez C, Rodrigo Nicolás B, Valcuende Cavero F. Enfermedad de Crohn metastásica tratada con ustekinumab. Actas Dermosifiliogr. 2021;112:182–183.</p>" ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 583 "Ancho" => 1300 "Tamanyo" => 194011 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Clinical image. B, Histological image.</p>" ] ] 1 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 586 "Ancho" => 1750 "Tamanyo" => 154477 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Clinical course.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metastatic Crohn’s Disease: An Approach to an Uncommon but Important Cutaneous Disorder" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Aberumand" 1 => "J. Howard" 2 => "J. Howard" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2017/9350537" "Revista" => array:4 [ "tituloSerie" => "Biomed Res Int" "fecha" => "2017" "volumen" => "2017" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29333457" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metastatic Crohn’s disease: a review and approach to therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D.J. Kurtzman" 1 => "T. Jones" 2 => "F. Lian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2014.04.002" "Revista" => array:7 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2014" "volumen" => "71" "numero" => "Oct" "paginaInicial" => "804" "paginaFinal" => "813" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24888520" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metastatic Crohn’s disease despite infliximab therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S. Campos" 1 => "I. Coutinho" 2 => "J.C. Cardoso" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "An Bras Dermatol" "fecha" => "2017" "volumen" => "92 5 Suppl 1" "paginaInicial" => "104" "paginaFinal" => "106" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metastatic Crohn’s disease. Response to adalimumab dose intensification" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Lázaro Saéz" 1 => "A. Hernández Martínez" 2 => "R.Á Bendezú García" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Gastroenterol Hepatol" "fecha" => "2012" "volumen" => "35" "numero" => "May" "paginaInicial" => "321" "paginaFinal" => "325" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of metastatic cutaneous Crohn disease with certolizumab" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Kiuru" 1 => "B. Camp" 2 => "K. Adhami" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Dermatol Online J" "fecha" => "2015" "volumen" => "18" "numero" => "Nov" "paginaInicial" => "11" "itemHostRev" => array:3 [ "pii" => "S0002870318302217" "estado" => "S300" "issn" => "00028703" ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ustekinumab for treatment of cutaneous Crohn’s disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Abdat" 1 => "A. Markova" 2 => "F.A. Farraye" 3 => "M.K. Lichtman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Dermatol Online J" "fecha" => "2016" "volumen" => "22" "numero" => "Oct" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011200000002/v1_202102100758/S1578219020303966/v1_202102100758/en/main.assets" "Apartado" => array:4 [ "identificador" => "6157" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case and Research Letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011200000002/v1_202102100758/S1578219020303966/v1_202102100758/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020303966?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 10 | 12 | 22 |
| 2024 October | 88 | 42 | 130 |
| 2024 September | 86 | 24 | 110 |
| 2024 August | 112 | 60 | 172 |
| 2024 July | 87 | 33 | 120 |
| 2024 June | 73 | 37 | 110 |
| 2024 May | 80 | 39 | 119 |
| 2024 April | 82 | 24 | 106 |
| 2024 March | 57 | 34 | 91 |
| 2024 February | 70 | 36 | 106 |
| 2024 January | 66 | 32 | 98 |
| 2023 December | 76 | 29 | 105 |
| 2023 November | 94 | 24 | 118 |
| 2023 October | 74 | 24 | 98 |
| 2023 September | 83 | 37 | 120 |
| 2023 August | 62 | 17 | 79 |
| 2023 July | 60 | 33 | 93 |
| 2023 June | 59 | 30 | 89 |
| 2023 May | 88 | 16 | 104 |
| 2023 April | 70 | 20 | 90 |
| 2023 March | 70 | 29 | 99 |
| 2023 February | 63 | 29 | 92 |
| 2023 January | 47 | 38 | 85 |
| 2022 December | 59 | 35 | 94 |
| 2022 November | 47 | 34 | 81 |
| 2022 October | 35 | 23 | 58 |
| 2022 September | 34 | 33 | 67 |
| 2022 August | 36 | 44 | 80 |
| 2022 July | 24 | 39 | 63 |
| 2022 June | 19 | 28 | 47 |
| 2022 May | 67 | 42 | 109 |
| 2022 April | 75 | 36 | 111 |
| 2022 March | 64 | 41 | 105 |
| 2022 February | 82 | 42 | 124 |
| 2022 January | 82 | 43 | 125 |
| 2021 December | 47 | 48 | 95 |
| 2021 November | 58 | 45 | 103 |
| 2021 October | 45 | 60 | 105 |
| 2021 September | 49 | 36 | 85 |
| 2021 August | 39 | 32 | 71 |
| 2021 July | 29 | 20 | 49 |
| 2021 June | 45 | 33 | 78 |
| 2021 May | 40 | 44 | 84 |
| 2021 April | 133 | 118 | 251 |
| 2021 March | 61 | 29 | 90 |
| 2021 February | 83 | 37 | 120 |
| 2021 January | 38 | 23 | 61 |
| 2020 December | 6 | 11 | 17 |
Show all
